◼ Archived
Business
🔮 Newsylist predicts: still trending tomorrow medium confidence — graded ✗ wrong
Newly approved pancreatic cancer drug shows promise in lung cancer
8sources
8articles
6velocity
+183%since first seen
3d agofirst detected
Sources (8)
- Pancreatic Cancer Drug Rasonque’s Price Indicates Sustainability Issue forbes.com · 3d ago
- RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer BioSpace · 3d ago
- New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer Yahoo Finance · 3d ago
- Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests ABC News - Breaking News, Latest News and Videos · 4d ago
- Scientists Built a Molecule From Ordinary Atoms—and It Doubled Survival for a ‘Hidden’ Cancer popularmechanics.com · 4d ago
- FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber News-Medical · 4d ago
- New pancreatic cancer drug gives South Portland man hope for longer life Portland Press Herald - Maine Sunday Telegram · 4d ago
- Newly approved pancreatic cancer drug shows promise in lung cancer NBC News · 4d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
◼ Archived
Business
🔮 holds ✗
Bank of Canada mulls Trump tariff shock as it readies interest rates decision
Bank of Canada pauses rate hikes at 2.25% while U.S. tariff threats loom over the economy.
◼ Archived
Business
🔮 fades ✓
Uber to cut 10% of its global workforce
Uber cuts 3,300 jobs, 10% of staff, to streamline and fund its robotaxi ambition.
◼ Archived
Business
🔮 fades ✓
Breman Speech: RBNZ Governor sheds light on policy outlook after interest rate hike
New Zealand’s central bank lifts its official cash rate to 2.75%, sparking debate over the timing of future hikes.
◼ Archived
Business
🔮 holds ✗
Anthropic upgrades Claude with new Fable 5.1 model, details here
Anthropic’s Claude Fable 5.1 debut arrives with a $35 billion Lambda cloud pact and promises lower costs and sharper coding skills.
◼ Archived
Business
🔮 holds ✗
Lowe's launches major effort to help close America's skilled trades gap
Lowe’s unveils a million‑person skilled‑trades coalition as AI fuels a surge in demand.
◼ Archived
Business
🔮 holds ✗
Asian Stocks to Fall as Iran Flare-Up Boosts Oil: Markets Wrap
Iran’s flare‑up spikes oil above $91, sending Asian equities and global bonds tumbling